Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (404)	6/24/1999 9:23:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 579

(When in doubt, start a thread...) Subject 27298 I can have the webmaster change the name if you like;-) Apparenly it was too narrow a topic to draw much attention, could change it to "Biotech patents", if there really was interest. Great discussion going on here, I prefer less talk however, especially when it is going over my head-- you're creeping me out, and sold half my SIBI. So stop it, or you'll shake me out of it entirely by the time it really pops. (lurkers: watch me, then do the opposite, enter market buy orders immediately on Sibia) Actually, PFE is the odd man out, Sibia has got licences from several big pharma outfits, so is that not a pretty good signal there?

To: Biomaven who wrote (404)	6/24/1999 10:17:00 PM
From: scaram(o)uche	Respond to of 579

>> PB is quite right here - PFE has multiple strings to their bow << They (chuckle) claim multiple strings. >> Maybe I should start a biotech patent thread << Good idea. It is likely that Greg Aharonian, Richard Aron Osman, and several others that have addressed these issues are lurking out there. Perhaps a good thread would at least focus some of their commentary, if not attract their participation. These individuals have already eloquently contributed on these issues.